GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mangalam Drugs & Organics Ltd (BOM:532637) » Definitions » Change In Receivables

Mangalam Drugs & Organics (BOM:532637) Change In Receivables : ₹0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Mangalam Drugs & Organics Change In Receivables?

Mangalam Drugs & Organics's change in receivables for the quarter that ended in Dec. 2023 was ₹0 Mil. It means Mangalam Drugs & Organics's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Mangalam Drugs & Organics's change in receivables for the fiscal year that ended in Mar. 2024 was ₹0 Mil. It means Mangalam Drugs & Organics's Accounts Receivable stayed the same from Mar. 2023 to Mar. 2024 .

Mangalam Drugs & Organics's Accounts Receivable for the quarter that ended in Dec. 2023 was ₹0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Mangalam Drugs & Organics's Days Sales Outstanding for the three months ended in Dec. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Mangalam Drugs & Organics's liquidation value for the three months ended in Dec. 2023 was ₹0 Mil.


Mangalam Drugs & Organics Change In Receivables Historical Data

The historical data trend for Mangalam Drugs & Organics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangalam Drugs & Organics Change In Receivables Chart

Mangalam Drugs & Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -223.53 -136.08 77.95 -0.52 -

Mangalam Drugs & Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mangalam Drugs & Organics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mangalam Drugs & Organics  (BOM:532637) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Mangalam Drugs & Organics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/970.459*91
=0.00

2. In Ben Graham's calculation of liquidation value, Mangalam Drugs & Organics's accounts receivable are only considered to be worth 75% of book value:

Mangalam Drugs & Organics's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0-0+0.75 * 0+0.5 * 0
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mangalam Drugs & Organics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Mangalam Drugs & Organics (BOM:532637) Business Description

Traded in Other Exchanges
Address
239, P. D’Mello Road, Rupam Building, 3rd Floor, Near General Post Office, Mumbai, MH, IND, 400001
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.

Mangalam Drugs & Organics (BOM:532637) Headlines

No Headlines